<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2025-18-4-107-112</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-1962</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Дифференцированный подход к лечению хронического конъюнктивита при постковидном синдроме на основе данных лазерной допплеровской флоуметрии</article-title><trans-title-group xml:lang="en"><trans-title>Differentiated approach to the treatment of chronic conjunctivitis in post-COVID syndrome based on data laser doppler flowmetry</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4601-0904</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сафонова</surname><given-names>Т. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Safonova</surname><given-names>T. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татьяна Николаевна Сафонова — канд. мед. наук, ведущий научный сотрудник отделения патологии слезного аппарата</p><p>ул. Россолимо, д. 11а, б, Москва, 119021</p></bio><bio xml:lang="en"><p>Tatiana  N.  Safonova  — Cand. of Med. Sci., leading researcher of the department of lacrimal system</p><p>11 A, B, Rossolimo St., Moscow, 119021</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8575-3076</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зайцева</surname><given-names>Г. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaitseva</surname><given-names>G. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Галина Валерьевна Зайцева — канд. мед. наук, научный сотрудник отделения патологии слезного аппарата</p><p>ул. Россолимо, д. 11а, б, Москва, 119021</p></bio><bio xml:lang="en"><p>Galina V. Zaitseva — Cand. of Med. Sci., researcher of the department of lacrimal system pathology</p><p>11 A, B, Rossolimo St., Moscow, 119021</p></bio><email xlink:type="simple">g.zaytseva@niigb.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2740-2793</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кинтюхина</surname><given-names>Н. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kintyukhina</surname><given-names>N. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталия Павловна Кинтюхина — канд. мед. наук, научный сотрудник отделения патологии слезного аппарата</p><p>ул. Россолимо, д. 11а, б, Москва, 119021</p></bio><bio xml:lang="en"><p>Natalia P. Kintyukhina — Cand. of Med. Sci., researcher of the department of lacrimal system pathology</p><p>11 A, B, Rossolimo St., Moscow, 119021</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «НИИ глазных болезней им. М.М. Краснова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Krasnov Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>09</day><month>01</month><year>2026</year></pub-date><volume>18</volume><issue>4</issue><fpage>107</fpage><lpage>112</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сафонова Т.Н., Зайцева Г.В., Кинтюхина Н.П., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Сафонова Т.Н., Зайцева Г.В., Кинтюхина Н.П.</copyright-holder><copyright-holder xml:lang="en">Safonova T.N., Zaitseva G.V., Kintyukhina N.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/1962">https://roj.igb.ru/jour/article/view/1962</self-uri><abstract><p>Цель работы — разработать дифференцированный подход к лечению хронического конъюнктивита при постковидном синдроме на основе данных лазерной допплеровской флоуметрии.</p><sec><title>Материал и методы</title><p>Материал и методы. Обследованы 66 пациентов (132 глаза) с хроническим неинфекционным конъюнктивитом в постковидном периоде, которым через 3 мес после перенесенного SARS-CoV-2 проводили лазерную допплеровскую флоуметрию бульбарной конъюнктивы По результатам флоуметрии пациенты были разделены на 2 группы: 1-ю — с гиперемическим и 2-ю — с застойным гемодинамическим типом микроциркуляции. В каждой группе были выделены две подгруппы. Пациентам подгруппы 1а (18 пациентов, 36 глаз) назначили местно антиоксидантное средство 3 раза в день 2 мес, увлажняющие препараты, содержащие гиалуронат натрия 3 раза в день, препарат, содержащий гепарин, в течение всего периода наблюдения, системно препарат из группы метаболических средств в течение 3 мес. Пациентам подгруппы 2а (15 пациентов, 30 глаз) рекомендовали инстилляции препаратов, содержащих гиалуронат натрия 3 раза в день, препарат, содержащий гепарин, в течение всего периода наблюдения и системно прием препарата из группы венотоников 3 мес. Пациенты подгрупп 1б и 2б получали лечение препаратом, содержащим гиалуронат натрия, 3 раза в день. Мониторинг эффективности терапии осуществляли через 1, 3, 6 мес.</p></sec><sec><title>Результаты</title><p>Результаты. После терапии гемодинамические показатели микроциркуляции значительно улучшились. Коррекция микроциркуляторных нарушений способствовала нормализации перфузии через 3 мес у пациентов подгруппы 1а (М = 24,8 ± 5,5 п. е.), через 6 мес у пациентов подгруппы 2а (М = 26,3 ± 6,1 п. е.) и механизмов ее регуляции через 6 мес у пациентов подгруппы 2а (Кv = 15,2 ± 7,4%). У пациентов подгрупп 1б и 2б статистически достоверных изменений микроциркуляторных показателей не зафиксировано.</p></sec><sec><title>Заключение</title><p>Заключение. Гиперемический или застойный тип гемодинамических микроциркуляторных нарушений, установленный при оценке базовых показателей (М, σ, Кv), служит основанием при выборе тактики лечения хронического конъюнктивита при постковидном синдроме.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: to develop a differentiated approach to the treatment of chronic conjunctivitis in post-Covid syndrome based on laser Doppler flowmetry (LDF) data.</p></sec><sec><title>Material and methods</title><p>Material and methods. The study included 66 patients (132 eyes) with chronic non-infectious conjunctivitis in the post-Covid period. All patients underwent LGF of the bulbar conjunctiva 3 months after SARS-CoV-2 infection. According to the results of LDF, patients were divided into 2 groups: 1-st with hyperemic and 2-nd with stagnant hemodynamic type of microcirculation. In each group, two subgroups were identified. Patients of subgroup 1-a (18 patients, 36 eyes) were prescribed topical antioxidant agent 3 times a day for 2 months, moisturizing preparations containing sodium hyaluronate 3 times a day, preparation containing heparin during the whole period of observation, systemically a preparation from the group of metabolic agents for 3 months. Patients of subgroup 2-a (15 patients, 30 eyes) were recommended instillations of preparations containing sodium hyaluronate 3 times a day, a preparation containing heparin during the whole period of observation and systemic administration of a preparation from the group of venotonics 3 months. Patients of subgroups 1-b and 2-b were treated with a preparation containing sodium hyaluronate 3 times a day. The effectiveness of therapy was monitored after 1, 3, 6 months.</p></sec><sec><title>Results</title><p>Results. After therapy hemodynamic parameters of microcirculation significantly improved. Correction of microcirculatory disorders contributed to normalization of perfusion in 3 months in patients of subgroup 1-a (M = 24.8 ± 5.5 p. u.), in 6 months in patients of subgroup 2-a (M = 26.3 ± 6.1 p. u.) and mechanisms of its regulation in 6 months in patients of subgroup 2-a (Kv = 15.2 ± 7.4 %). No statistically significant changes in microcirculatory parameters were registered in patients of subgroups 1-b and 2-b.</p></sec><sec><title>Conclusion</title><p>Conclusion. Hyperemic or stagnant type of hemodynamic microcirculatory disorders, established by the evaluation of baseline indices (M, σ, Kv), serves as a basis for the choice of treatment tactics for chronic conjunctivitis in postconcussive syndrome.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>постковидный синдром</kwd><kwd>конъюнктива</kwd><kwd>хронический конъюнктивит</kwd><kwd>лазерная допплеровская флоуметрия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>post-COVID syndrome</kwd><kwd>conjunctiva</kwd><kwd>chronic conjunctivitis</kwd><kwd>laser Doppler flowmetry</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Zayet S, Zahra H, Royer PY, et al. Post-COVID-19 syndrome: Nine months after SARS-CoV-2 infection in a cohort of 354 patients: Data from the first wave of COVID-19 in Nord Franche-Comté Hospital, France. Microorganisms. 2021; 9 (8): 1719. doi: 10.3390/microorganisms9081719</mixed-citation><mixed-citation xml:lang="en">Zayet S, Zahra H, Royer PY, et al. Post-COVID-19 syndrome: Nine months after SARS-CoV-2 infection in a cohort of 354 patients: Data from the first wave of COVID-19 in Nord Franche-Comté Hospital, France. Microorganisms. 2021; 9 (8): 1719. doi: 10.3390/microorganisms9081719</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Puntmann VO, Martin S, Shchendrygina A, et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med. 2022; 28 (10): 2117–23. doi: 10.1038/s41591-022-02000-0</mixed-citation><mixed-citation xml:lang="en">Puntmann VO, Martin S, Shchendrygina A, et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med. 2022; 28 (10): 2117–23. doi: 10.1038/s41591-022-02000-0</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM; Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022; 400 (10350): 452–61. doi: 10.1016/S0140-6736(22)01214-4</mixed-citation><mixed-citation xml:lang="en">Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM; Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022; 400 (10350): 452–61. doi: 10.1016/S0140-6736(22)01214-4</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Исаева А.В., Ветлужская М.В., Коробейникова А.Н., Власова А.В. Клинические фенотипы и особенности течения постковидного синдрома. Профилактическая медицина. 2023; 26 (9): 66–73. doi: 10.17116/profmed20232609166</mixed-citation><mixed-citation xml:lang="en">Isaeva A.V., Vetluzhskaya M.V., Korobeynikova A.N., Vlasova A.V. Clinical phenotypes and features of the post-COVID syndrome course. Russian journal of preventive medicine. 2023; 26 (9): 66–73 (In Russ.). doi: 10.17116/profmed20232609166</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022; 22 (4): e102-e107. doi: 10.1016/S1473-3099(21)00703-9</mixed-citation><mixed-citation xml:lang="en">Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022; 22 (4): e102-e107. doi: 10.1016/S1473-3099(21)00703-9</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021; 53 (10): 737–54. doi: 10.1080/23744235.2021.1924397</mixed-citation><mixed-citation xml:lang="en">Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021; 53 (10): 737–54. doi: 10.1080/23744235.2021.1924397</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chen C, Haupert SR, Zimmermann L, et al. Global prevalence of postCoronavirus disease 2019 (COVID-19) condition or long COVID: a metaanalysis and systematic review. J Infect Dis. 2022; 226 (9): 1593–607. doi: 10.1093/infdis/jiac136</mixed-citation><mixed-citation xml:lang="en">Chen C, Haupert SR, Zimmermann L, et al. Global prevalence of postCoronavirus disease 2019 (COVID-19) condition or long COVID: a metaanalysis and systematic review. J Infect Dis. 2022; 226 (9): 1593–607. doi: 10.1093/infdis/jiac136</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Líška D, Liptaková E, Babičová A, et al. What is the quality of life in patients with long COVID compared to a healthy control group? Front Public Health. 2022; 10: 975992. doi: 10.3389/fpubh.2022.975992</mixed-citation><mixed-citation xml:lang="en">Líška D, Liptaková E, Babičová A, et al. What is the quality of life in patients with long COVID compared to a healthy control group? Front Public Health. 2022; 10: 975992. doi: 10.3389/fpubh.2022.975992</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38: 101019. doi: 10.1016/j.eclinm.2021.101019</mixed-citation><mixed-citation xml:lang="en">Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38: 101019. doi: 10.1016/j.eclinm.2021.101019</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Perlis RH, Lunz Trujillo K, Safarpour A, et al. Association of Post-COVID-19 condition symptoms and employment status. JAMA Netw Open. 2023; 6 (2): e2256152. doi: 10.1001/jamanetworkopen.2022.56152</mixed-citation><mixed-citation xml:lang="en">Perlis RH, Lunz Trujillo K, Safarpour A, et al. Association of Post-COVID-19 condition symptoms and employment status. JAMA Netw Open. 2023; 6 (2): e2256152. doi: 10.1001/jamanetworkopen.2022.56152</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022; 36 (7): 681–702. doi: 10.1007/s40263-022-00931-3</mixed-citation><mixed-citation xml:lang="en">Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022; 36 (7): 681–702. doi: 10.1007/s40263-022-00931-3</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mantovani A, Morrone MC, Patrono C, et al. Long Covid: where we stand and challenges ahead. Cell Death Differ. 2022; 29 (10): 1891–900. doi: 10.1038/s41418-022-01052-6</mixed-citation><mixed-citation xml:lang="en">Mantovani A, Morrone MC, Patrono C, et al. Long Covid: where we stand and challenges ahead. Cell Death Differ. 2022; 29 (10): 1891–900. doi: 10.1038/s41418-022-01052-6</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bahmer T, Borzikowsky C, Lieb W, et al. Severity, predictors and clinical correlates of post-COVID syndrome (PCS) in Germany: A prospective, multicentre, population-based cohort study. EClinicalMedicine. 2022; 51: 101549. doi: 10.1016/j.eclinm.2022.101549</mixed-citation><mixed-citation xml:lang="en">Bahmer T, Borzikowsky C, Lieb W, et al. Severity, predictors and clinical correlates of post-COVID syndrome (PCS) in Germany: A prospective, multicentre, population-based cohort study. EClinicalMedicine. 2022; 51: 101549. doi: 10.1016/j.eclinm.2022.101549</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Асфандиярова Н.С. Постковидный синдром. Клиническая медицина. 2021; 99 (7–8): 429–35.</mixed-citation><mixed-citation xml:lang="en">Asfandiyarova N.S. Post-COVID syndrome. Klinicheskaya meditsina. 2021; 99 (7–8): 429–35 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Phetsouphanh C, Darley DR, Wilson DB, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022; 23 (2): 210–6. doi: 10.1038/s41590-021-01113-x</mixed-citation><mixed-citation xml:lang="en">Phetsouphanh C, Darley DR, Wilson DB, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022; 23 (2): 210–6. doi: 10.1038/s41590-021-01113-x</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Калюжная Е.Н., Пономарева М.Н., Петров И.М. и др. Влияние этиопатогенетической терапии на микроциркуляцию бульбарной конъюнктивы у пациентов с дислипидемией, перенесших COVID-19-ассоциированную пневмонию. Российский офтальмологический журнал. 2021; 14 (2): 7–13. https://doi.org/10.21516/2072-0076-2021-14-2-7-13</mixed-citation><mixed-citation xml:lang="en">Kalyuzhnaya E.N., Ponomareva M.N., Petrov I.M., et al. Etiopathogenetic therapy effect on the microcirculation of the bulbar conjunctiva in patients with dyslipidemia after COVID-19 associated pneumonia. Russian ophthalmological journal. 2021; 14 (2): 7–13 (In Russ.). https://doi.org/10.21516/2072-0076-2021-14-2-7-13</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Chandra A, Seidelmann SB, Claggett BL, et al. The association of retinal vessel calibres with heart failure and long-term alterations in cardiac structure and function: the Atherosclerosis Risk in Communities (ARIC) Study. Eur J Heart Fail. 2019; 21 (10): 1207–15. doi: 10.1002/ejhf.1564</mixed-citation><mixed-citation xml:lang="en">Chandra A, Seidelmann SB, Claggett BL, et al. The association of retinal vessel calibres with heart failure and long-term alterations in cardiac structure and function: the Atherosclerosis Risk in Communities (ARIC) Study. Eur J Heart Fail. 2019; 21 (10): 1207–15. doi: 10.1002/ejhf.1564</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gnthner R, Streese L, Angermann S, et al. Mortality prediction of retinal vessel diameters and function in a long-term follow-up of haemodialysis patients. Cardiovasc Res. 2022; 118 (16): 3239–49. doi: 10.1093/cvr/cvac073</mixed-citation><mixed-citation xml:lang="en">Gnthner R, Streese L, Angermann S, et al. Mortality prediction of retinal vessel diameters and function in a long-term follow-up of haemodialysis patients. Cardiovasc Res. 2022; 118 (16): 3239–49. doi: 10.1093/cvr/cvac073</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Сафонова Т.Н., Луцевич Е.Э., Кинтюхина Н.П. Изменение микроциркуляции бульбарной конъюнктивы при различных заболеваниях. Вестник офтальмологии. 2016; 132 (2): 90–5. https://doi.org/10.17116/oftalma2016132290-95</mixed-citation><mixed-citation xml:lang="en">Safonova T.N., Lutsevich E.Е., Kintukhina N.P. Microcirculatory changes in bulbar conjunctiva in various diseases. Vestnik oftal’mologii. 2016; 132 (2): 90–5 (In Russ.). https://doi.org/10.17116/oftalma2016132290-95</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Сафонова Т.Н., Кинтюхина Н.П., Ярцев В.Д. Морфофункциональное обоснование проведения повторных курсов инвазивного лечения хронического блефарита. Вестник офтальмологии. 2021; 137 (1): 21–7. https://doi.org/10.17116/oftalma202113701121</mixed-citation><mixed-citation xml:lang="en">Safonova T.N., Kintyukhina N.P., Yartsev V.D. Morphofunctional substantiation of repeated invasive treatment of chronic blepharitis. Vestnik oftal’mologii. 2021; 137 (1): 21–7 (In Russ.). https://doi.org/10.17116/oftalma202113701121</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Сафонова Т.Н., Зайцева Г.В., Кинтюхина Н.П. Влияние новой коронавирусной инфекции, вызванной вирусом SARS-CoV-2, на микроциркуляцию в конъюнктиве. Медицинский совет. 2022; 16 (14): 206–11. https://doi.org/10.21518/2079-701X-2022-16-14-206-211</mixed-citation><mixed-citation xml:lang="en">Safonova T.N., Zaitseva G.V., Kintyukhina N.P. The effect of a new coronavirus infection caused by the SARS-CoV-2 virus on microcirculation in the conjunctiva. Meditsinskiy Sovet. 2022; 16 (14): 206–11 (In Russ.). https://doi.org/10.21518/2079-701X-2022-16-14-206-211</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Сафонова Т.Н., Зайцева Г.В., Кинтюхина Н.П., Медведева Е.С. Способ коррекции микроциркуляторных нарушений при постковидном синдроме. Патент РФ № 2791660 от 13.03.2023.</mixed-citation><mixed-citation xml:lang="en">Safonova T.N., Zajceva G.V., Kintyuhina N.P., Medvedeva E.S. A method for correcting microcirculatory disorders in post-COVID syndrome. Patent RF № 2791660, 13.03.2023 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Safonova TN, Zaitseva GV. Pathogenetic mechanisms of dry eye syndrome in a novel coronavirus infection caused by SARS-CoV-2. Russian Open Medical Journal. 2022; 11: e0306. doi: 10.15275/rusomj.2022.0306</mixed-citation><mixed-citation xml:lang="en">Safonova TN, Zaitseva GV. Pathogenetic mechanisms of dry eye syndrome in a novel coronavirus infection caused by SARS-CoV-2. Russian Open Medical Journal. 2022; 11: e0306. doi: 10.15275/rusomj.2022.0306</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Литвицкий П.Ф. Нарушения регионарного кровотока и микроциркуляции. Регионарное кровообращение и микроциркуляция. 2020; 19 (1): 82–92. https://doi.org/10.24884/1682-6655-2020-19-1-82-92</mixed-citation><mixed-citation xml:lang="en">Litvitskiy P.F. Regional blood flow and microcirculation disorders. Regional hemodynamics and microcirculation. 2020; 19 (1): 82–92 (In Russ.). https://doi.org/10.24884/1682-6655-2020-19-1-82-92</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">McGonagle D, O’Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020; 2 (7): e437-e445. doi: 10.1016/S2665-9913(20)30121-1</mixed-citation><mixed-citation xml:lang="en">McGonagle D, O’Donnell JS, Sharif K, Emery P, Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020; 2 (7): e437-e445. doi: 10.1016/S2665-9913(20)30121-1</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Путилина М.В. Алгоритм диагностики и терапии хронических форм нарушений венозного кровообращения. Лечащий врач. 2015 (6): 66–72.</mixed-citation><mixed-citation xml:lang="en">Putilina M.V. Algorithm of diagnostics and therapy of chronic forms of venous circulation disorders. Lechashchii vrach. 2015 (6): 66–72 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Богачев В.Ю., Мансилья А., Болдин Б.В., Родионов С.В., Дженина О.В. Патогенетическое обоснование флеботропной терапии хронических заболеваний вен. Стационарозамещающие технологии. Амбулаторная хирургия. 2019; (3–4): 19–33. https://doi.org/10.21518/1995-1477-2019-3-4-19-33</mixed-citation><mixed-citation xml:lang="en">Bogachev V.Yu., Mansilla A., Boldin B.V., Rodionov S.V., Dzhenina O.V. Pathogenetic substantiation of phlebotropic therapy for chronic venous diseases. Нospitalreplacing technologies: Ambulatory surgery. 2019; (3–4): 19–33 (In Russ.). https://doi.org/10.21518/1995-1477-2019-3-4-19-33</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Hanssen H, Streese L, Vilser W. Retinal vessel diameters and function in cardiovascular risk and disease. Prog Retin Eye Res. 2022; 91: 101095. doi: 10.1016/j.preteyeres.2022.101095</mixed-citation><mixed-citation xml:lang="en">Hanssen H, Streese L, Vilser W. Retinal vessel diameters and function in cardiovascular risk and disease. Prog Retin Eye Res. 2022; 91: 101095. doi: 10.1016/j.preteyeres.2022.101095</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Aydemir E, Aydemir GA, Atesoglu HI, et al. The impact of coronavirus disease 2019 (COVID-19) on retinal microcirculation in human subjects. Klin Monbl Augenheilkd. 2021; 238 (12): 1305–11. doi:10.1055/a-1579-0805</mixed-citation><mixed-citation xml:lang="en">Aydemir E, Aydemir GA, Atesoglu HI, et al. The impact of coronavirus disease 2019 (COVID-19) on retinal microcirculation in human subjects. Klin Monbl Augenheilkd. 2021; 238 (12): 1305–11. doi:10.1055/a-1579-0805</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
